- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Medium dose of BIIL 284 BS tablets
Total 1114 results
-
Viatris Inc.Not yet recruiting
-
Mutual Pharmaceutical Company, Inc.Completed
-
Mutual Pharmaceutical Company, Inc.Completed
-
Actavis Inc.CompletedHealthyUnited States
-
Actavis Inc.Completed
-
UCB BIOSCIENCES, Inc.Pharmaceutical Research AssociatesCompletedEpilepsyUnited States, Australia, Belgium, Brazil, Bulgaria, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Taiwan
-
Mario Negri Institute for Pharmacological ResearchMinistry of Health, Italy; Azienda Ospedaliera San Gerardo di MonzaActive, not recruiting
-
Torrent Pharmaceuticals LimitedCompleted
-
Jan Kochanowski UniversityRecruiting
-
University of Colorado, DenverWithdrawn
-
IpsenCompleted
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical CenterRecruitingBRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Ovarian Neoplasm EpithelialNetherlands
-
Torrent Pharmaceuticals LimitedCompleted
-
GlaxoSmithKlineCompleted
-
Assiut UniversityCompleted
-
Bial - Portela C S.A.Terminated
-
GlaxoSmithKlineCompleted
-
Actavis Inc.Completed
-
UCB PharmaCompleted
-
Tanta UniversityActive, not recruiting
-
Sinovac Life Sciences Co., Ltd.Completed
-
Mayo ClinicEnrolling by invitationHeart Failure; With DecompensationUnited States
-
Jazz PharmaceuticalsQuintiles, Inc.CompletedPain | Cancer | Palliative CareSpain, United Kingdom, United States, Canada, Poland, India, France, Czech Republic, Belgium, Romania, Chile, Finland, Germany, Italy, Mexico, South Africa
-
GlaxoSmithKlineCompleted
-
Novartis PharmaceuticalsRecruiting
-
Paddock Laboratories, Inc.Completed
-
Vectura, Inc.Syneos HealthTerminatedObstructive Pulmonary Function | Restrictive Pulmonary FunctionUnited States
-
Eisai Co., Ltd.CompletedLennox-Gastaut SyndromeJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedType 2 Diabetes MellitusJapan
-
Pharma NuevaNot yet recruiting
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); GlaxoSmithKlineCompletedCardiovascular DiseaseUnited States
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Xiangbei Welman Pharmaceutical Co., LtdSuspendedRespiratory Tract Infections | Urinary Tract InfectionsChina
-
German Breast GroupNovartisCompletedBreast Cancer | Hormone Receptor Positive TumorGermany
-
Daiichi Sankyo, Inc.Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedEssential HypertensionFrance, Poland, Ukraine, Germany, Spain, Bulgaria, Czechia
-
Federal University of Rio Grande do SulCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.Completed
-
SK Bioscience Co., Ltd.Coalition for Epidemic Preparedness InnovationsCompletedCOVID-19 (Healthy Volunteers)Korea, Republic of
-
University of Michigan Rogel Cancer CenterRush University Medical CenterCompletedPancreatic CancerUnited States
-
BDD Pharma LtdDrug Delivery International LtdCompleted
-
Hospices Civils de LyonCompletedCarotid Artery PlaqueFrance
-
McGill University Health Centre/Research Institute...RecruitingESRD | CKD Stage 4 | CKD Stage 5Canada
-
Terran Biosciences Australia Pty LtdRecruiting
-
Czech CLL Study GroupUnknownChronic Lymphocytic LeukemiaCzech Republic
-
YangjinPeking University Third HospitalNot yet recruitingPrediabetic State | Impaired Glucose Tolerance | Impaired Fasting GlucoseChina
-
Bial - Portela C S.A.Completed
-
GlaxoSmithKlineCompleted
-
Foghorn Therapeutics Inc.RecruitingRefractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Relapsed Acute Myeloid Leukemia | Relapsed Myelodysplastic Syndromes | Refractory Myelodysplastic Syndromes | Advanced Hematologic Malignancy | Relapsed Chronic Myelomonocytic LeukemiaUnited States
-
Translational Research Center for Medical Innovation...Gastro-Intestinal Medical Care Research CenterCompletedCardio-cerebrovascular DiseaseJapan
-
Nordsjaellands HospitalInnovation Fund DenmarkCompleted